Variant report
Variant | esv3338177 |
---|---|
Chromosome Location | chr2:51734298-51736496 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KNOP1P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141686343 | chr2:51734300-51734301 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs565475651 | chr2:51734301-51734302 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs28958290 | chr2:51734317-51734318 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs183520665 | chr2:51734348-51734349 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs62143041 | chr2:51734353-51734354 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs567916181 | chr2:51734375-51734376 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs538180912 | chr2:51734381-51734382 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs556672876 | chr2:51734390-51734391 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs571882140 | chr2:51734410-51734411 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs188599325 | chr2:51734412-51734413 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs543354131 | chr2:51734573-51734574 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs28958292 | chr2:51734587-51734588 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs187072981 | chr2:51734589-51734590 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs28958293 | chr2:51734603-51734604 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs189986952 | chr2:51734623-51734624 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs377343160 | chr2:51734637-51734638 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs182572240 | chr2:51734639-51734640 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs1528804 | chr2:51734676-51734677 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs138946511 | chr2:51734680-51734681 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs7603619 | chr2:51734686-51734687 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs28958294 | chr2:51734752-51734753 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs572020507 | chr2:51734765-51734766 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs550656732 | chr2:51734786-51734787 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs377176398 | chr2:51734835-51734836 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs539215508 | chr2:51734877-51734878 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs7564790 | chr2:51734924-51734925 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs186472391 | chr2:51734964-51734965 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs536367469 | chr2:51734975-51734976 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs143901421 | chr2:51735051-51735052 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs567870277 | chr2:51735056-51735057 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs529102118 | chr2:51735072-51735073 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs1919424 | chr2:51735079-51735080 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs558425387 | chr2:51735128-51735129 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs576755209 | chr2:51735131-51735132 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs68052961 | chr2:51735133-51735134 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs550843085 | chr2:51735134-51735135 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs1919426 | chr2:51735138-51735139 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs546591549 | chr2:51735147-51735148 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs529695818 | chr2:51735183-51735184 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs566740077 | chr2:51735208-51735209 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs541570892 | chr2:51735230-51735231 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs201544037 | chr2:51735238-51735239 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs13415393 | chr2:51735239-51735240 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs185180249 | chr2:51735244-51735245 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs191560929 | chr2:51735263-51735264 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs563439043 | chr2:51735277-51735278 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs182897736 | chr2:51735291-51735292 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs530424584 | chr2:51735327-51735328 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs188819118 | chr2:51735344-51735345 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs565564625 | chr2:51735368-51735369 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51734600-51735800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr2:51734600-51736000 | Enhancers | HUVEC | blood vessel |
3 | chr2:51734600-51736000 | Enhancers | NH-A | brain |
4 | chr2:51734600-51736000 | Enhancers | Osteobl | bone |
5 | chr2:51735000-51735600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr2:51735600-51740200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr2:51736000-51737400 | Weak transcription | HUVEC | blood vessel |